Search Results - "Luciana Armaganijan"

Anticoagulantes Orais Diretos versus Aspirina para Prevenção Secundária de Acidente Vascular Cerebral em Pacientes com Acidente Vascular Cerebral Embólico de Fonte Indeterminada: Revisão Sistemática e Metanálise Atualizada de Ensaios Clínicos Randomizados

Authors: Juan Armando Talavera Larissa Teixeira Thomas Costa Alexandre et al.

Source: Arquivos Brasileiros de Cardiologia, Vol 122, Iss 6 (2025)

Subject Terms: Anticoagulantes, Inibidores da Agregação Plaquetária, AVC Embólico, Diseases of the circulatory (Cardiovascular) system, RC666-701

File Description: electronic resource

Relation: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2025000600401&lng=pt&tlng=pt; http://www.scielo.br/pdf/abc/v122n6/0066-782x-abc-122-6-e20240586.pdf; https://doaj.org/toc/1678-4170

Access URL: https://doaj.org/article/3359806a79b34518a93ad42c3c807873

Amplitude das Ondas F como Preditor de Tromboembolismo e de Sucesso da Cardioversão Elétrica em Pacientes com Fibrilação Atrial Persistente

Authors: Renan Teixeira Campelo Luciana Armaganijan Dalmo A. R. Moreira et al.

Source: Arquivos Brasileiros de Cardiologia (2022)

Subject Terms: Fibrilação Atrial, Eletrocardiografia, Tromboembolia, Eletrofisiologia, Diseases of the circulatory (Cardiovascular) system, RC666-701

File Description: electronic resource

Relation: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2022005016201&tlng=en; http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2022005016201&tlng=pt; https://doaj.org/toc/1678-4170

Access URL: https://doaj.org/article/bf1da977e96f4697939d1db54c8e6028

Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES

Authors: P. Gabriel Steg Michael Szarek J. Wouter Jukema et al.

Source: Circulation, 151, 14, pp. 1047-1050
ODYSSEY OUTCOMES Investigators & Poulsen, S H 2025, 'Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy : An Analysis of the Placebo Arm of ODYSSEY OUTCOMES', Circulation, vol. 151, no. 14, pp. 1047-1050. https://doi.org/10.1161/CIRCULATIONAHA.124.071269

Subject Terms: c-reactive protein, lipoprotein(a), biomarkers, cholesterol, Cardiology - Radboud University Medical Center

Access URL: https://pubmed.ncbi.nlm.nih.gov/40193536
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/320894
https://doi.org/10.1161/CIRCULATIONAHA.124.071269
https://hdl.handle.net/2066/320894
https://pure.au.dk/portal/en/publications/418c9ede-35a6-4960-b756-c9f344eedebc
https://doi.org/10.1161/CIRCULATIONAHA.124.071269
http://www.scopus.com/inward/record.url?scp=105002284560&partnerID=8YFLogxK

Recomendações para o Manejo de Dispositivos Cardíacos Eletrônicos Implantáveis Post Mortem

Authors: Júlio César de Oliveira Alexsandro Alves Fagundes Ricardo Alkmim-Teixeira et al.

Source: Arquivos Brasileiros de Cardiologia, Vol 115, Iss 6, Pp 1178-1179 (2021)

Subject Terms: Dispositivos Cardíacos Eletrônicos Implantáveis/complicações, Ética Baseada em Princípios, Autópsia/métodos, Diseases of the circulatory (Cardiovascular) system, RC666-701

File Description: electronic resource

Relation: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2020001401178&tlng=pt; http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2020001401178&tlng=en; http://www.scielo.br/pdf/abc/v115n6/0066-782X-abc-115-06-1178.pdf; http://www.scielo.br/pdf/abc/v115n6/en_0066-782X-abc-115-06-1178.pdf; https://doaj.org/toc/1678-4170

Access URL: https://doaj.org/article/3c9d09b9ae794460b3b78b504aa9f01c

Denervação Renal com Cateter Irrigado em Hipertensos Resistentes: Uma Estratégia Promissora?

Authors: Luciana Armaganijan Rodolfo Staico Aline Moraes et al.

Source: Arquivos Brasileiros de Cardiologia, Vol 102, Iss 4, Pp 355-363 (2014)

Subject Terms: Ablação por cateter, Rim / inervação, Simpatectomia / métodos, Procedimentos cirúrgicos minimamente invasivos, Diseases of the circulatory (Cardiovascular) system, RC666-701

File Description: electronic resource

Relation: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2014000400006&lng=en&tlng=en; https://doaj.org/toc/1678-4170

Access URL: https://doaj.org/article/d878a405b7c84cb0ae3841d5d2644a8a

Blood Pressure Control and Clinical Outcomes After Renal Denervation Through Irrigated Catheter Radiofrequency Ablation in Patients with Resistant Hypertension: A Case Series with Up to 10 Years of Follow-Up

Authors: Luna Varela do Carmo Kelton Dantas Pereira Marco Aurelio Goulart et al.

Source: High Blood Pressure & Cardiovascular Prevention. 31:687-694

Subject Terms: Male, Adult, Time Factors, Drug Resistance, Blood Pressure, Middle Aged, Blood Pressure Monitoring, Ambulatory, Kidney, Treatment Outcome, Renal Artery, Risk Factors, Hypertension, Catheter Ablation, Humans, Female, Sympathectomy, Therapeutic Irrigation, Antihypertensive Agents, Retrospective Studies

Access URL: https://pubmed.ncbi.nlm.nih.gov/39557771

Stroke Prevention in Atrial Fibrillation: Latest Clinical Trials and Guidelines

Authors: Luciana Armaganijan Cristiano Dietrich Dimpi Patel et al.

Source: Pharmaceuticals, Vol 5, Iss 4, Pp 384-397 (2012)

Subject Terms: atrial fibrillation, anticoagulants, stroke, prevention, Medicine, Pharmacy and materia medica, RS1-441

File Description: electronic resource

Relation: http://www.mdpi.com/1424-8247/5/4/384/; https://doaj.org/toc/1424-8247

Access URL: https://doaj.org/article/252c17b4c1d74da18b92a1f6e8f6c9ae

Do Omega-3 fatty acids prevent atrial fibrillation after open heart surgery? A meta-analysis of randomized controlled trials

Authors: Luciana Armaganijan Renato D Lopes Jeff S Healey et al.

Source: Clinics, Vol 66, Iss 11, Pp 1923-1928 (2011)

Subject Terms: Omega-3 fatty acids, Atrial fibrillation, Meta-analysis, Open Heart surgery, Prevention, Medicine (General), R5-920

File Description: electronic resource

Relation: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322011001100012; https://doaj.org/toc/1807-5932; https://doaj.org/toc/1980-5322

Access URL: https://doaj.org/article/c07791461bb94f46826f726e4f76daf4

Omega-3 Polyunsaturated Fatty Acid Supplementation Reduced Atrial Fibrillation Recurrence after Pulmonary Vein Antrum Isolation

Authors: Dimpi Patel Mazen Shaheen Preeti Venkatraman et al.

Source: Indian Pacing and Electrophysiology Journal, Vol 9, Iss 6, Pp 292-298 (2009)

Subject Terms: Polyunsaturated Fatty acids (PUFA), Atrial Fibrillation (AF), Pulmonary vein isolation (PVAI), Diseases of the circulatory (Cardiovascular) system, RC666-701

File Description: electronic resource

Relation: http://www.ipej.org/0906/patel.htm; https://doaj.org/toc/0972-6292

Access URL: https://doaj.org/article/d51d278278924219a6fb83a3dbf4547c

Emergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry: sex differences in treatment and outcomes in the Global RE-LY AF Registry

Authors: Linda S Johnson Yuxuan Jiang Judy Luu et al.

Source: Eur Heart J

Subject Terms: Male, Emergency Service, Emergency Room Visits, Emergency department, Hospital/statistics & numerical data, Population, Anticoagulants, Middle Aged, Atrial Fibrillation/therapy, Atrial fibrillation, Sex Factors, Females, Kardiologi och kardiovaskulära sjukdomar, Anticoagulants/therapeutic use, Rapid Communications, Sex differences, Atrial Fibrillation, Humans, Female, Registries, Emergency Service, Hospital, Stroke/TIA, Cardiology and Cardiovascular Disease, Aged

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/38833334
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-540596

Conduction system pacing versus biventricular pacing in heart failure with reduced ejection fraction: A systematic review and meta-analysis of randomized controlled trials

Authors: Iuri Ferreira Felix Michelle Collini Rafaela Fonseca et al.

Source: Heart Rhythm. 21:881-889

Subject Terms: Cardiac Resynchronization Therapy, Heart Failure, Heart Conduction System, Humans, Stroke Volume, Randomized Controlled Trials as Topic

Access URL: https://pubmed.ncbi.nlm.nih.gov/38382686

Predictors of bleeding and thrombotic events among patients admitted to the hospital with COVID-19 and elevated D-dimer: insights from the ACTION randomized clinical trial

Authors: Pedro Gabriel Melo, de Barros E Silva Remo H M, Furtado Mariana Silveira, de Alcântara Chaud et al.

Source: Journal of Thrombosis and Thrombolysis. 57:1031-1039

Subject Terms: Fibrin Fibrinogen Degradation Products, Male, Hospitalization, Risk Factors, SARS-CoV-2, Humans, COVID-19, Anticoagulants, Hemorrhage, Female, Thrombosis, Middle Aged, Aged

Access URL: https://pubmed.ncbi.nlm.nih.gov/38762708

Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation

Authors: Shaun G Goodman Philippe Gabriel Steg Michael Szarek et al.

Contributors: Shaun G Goodman Philippe Gabriel Steg Michael Szarek et al.

Source: Eur Heart J Cardiovasc Pharmacother
European Heart Journal-Cardiovascular Pharmacotherapy, 10, 4, pp. 342-352
European heart journal. Cardiovascular pharmacotherapy., Oxford : Oxford University Press, 2024, vol. 10, iss. 4, p. 342-352.
ODYSSEY OUTCOMES Investigators & Poulsen, S H 2024, 'Safety of the PCSK9 inhibitor alirocumab : insights from 47 296 patient-years of observation', European heart journal-Cardiovascular pharmacotherapy, vol. 10, no. 4, pp. 342-352. https://doi.org/10.1093/ehjcvp/pvae025

Subject Terms: safety, Serine Proteinase Inhibitors, Time Factors, Anticholesteremic Agents/adverse effects, Clinical Sciences, Clinical Trials and Supportive Activities, ODYSSEY OUTCOMES Investigators, alirocumab, Review, Cardiorespiratory Medicine and Haematology, Antibodies, Monoclonal, Humanized, Cardiovascular medicine and haematology, Antibodies, LDL, PCSK9, Clinical Research, Monoclonal, Humans, Serine Proteinase Inhibitors/adverse effects, Humanized, Cardiology - Radboud University Medical Center, Dyslipidemias, Randomized Controlled Trials as Topic, cholesterol, Biomedical and Clinical Sciences, Anticholesteremic Agents, Dyslipidemias/drug therapy, PCSK9 Inhibitors, Pharmacology and Pharmaceutical Sciences, Cholesterol, LDL, 3. Good health, Proprotein Convertase 9/metabolism, Good Health and Well Being, Cholesterol, Treatment Outcome, Cholesterol, LDL/blood, Antibodies, Monoclonal, Humanized/adverse effects, Cardiovascular Diseases, 6.1 Pharmaceuticals, Patient Safety, Safety, Proprotein Convertase 9, Cardiovascular Diseases/prevention & control, Biomarkers/blood, Biomarkers, Alirocumab

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/38658193
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/311065
https://doi.org/10.1093/ehjcvp/pvae025
https://repository.ubn.ru.nl//bitstream/handle/2066/311065/311065.pdf
https://hdl.handle.net/2066/311065
https://repository.vu.lt/VU:ELABAPDB203871008&prefLang=en_US

Direct Oral Anticoagulants versus Aspirin for Secondary Stroke Prevention in Patients with Embolic Stroke of Undetermined Source: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials

Authors: Juan Armando Talavera Larissa Teixeira Thomas Costa Alexandre et al.

Source: Arquivos Brasileiros de Cardiologia. 122

Abstract 4142748: Direct Oral Anticoagulants Versus Aspirin for Secondary Stroke Prevention in Patients with Embolic Stroke of Undetermined Source: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials

Authors: Juan Armando Talavera Larissa Teixeira Thomaz Costa et al.

Source: Circulation. 150

Subject Terms: 03 medical and health sciences, 0302 clinical medicine

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Authors: Emil Hagström P. Gabriel Steg Michael Szarek et al.

Contributors: Emil Hagström P. Gabriel Steg Michael Szarek et al.

Source: Circulation
Circulation, 146, 9, pp. 657-672
Hagström, E, Steg, P G, Szarek, M, Bhatt, D L, Bittner, V A, Danchin, N, Diaz, R, Goodman, S G, Harrington, R A, Jukema, J W, Liberopoulos, E, Marx, N, McGinniss, J, Manvelian, G, Pordy, R, Scemama, M, White, H D, Zeiher, A M, Schwartz, G G, ODYSSEY OUTCOMES Investigators & Bøttcher, M 2022, 'Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab', Circulation, vol. 146, no. 9, pp. 657-672. https://doi.org/10.1161/CIRCULATIONAHA.121.057807
Circulation, vol 146, iss 9
Circulation : an official journal of the American Heart Association / ed.-in-chief Ephraim Donosco 146(9), 657-672 (2022). doi:10.1161/CIRCULATIONAHA.121.057807

Subject Terms: Cardiovascular Diseases: diagnosis, Hydroxymethylglutaryl-CoA Reductase Inhibitors: therapeutic use, Anticholesteremic Agents/adverse effects, alirocumab, heart disease risk factors, Atherosclerosis: drug therapy, 0302 clinical medicine, Risk Factors, Original Research Articles, Monoclonal, Acute Coronary Syndrome: diagnosis, apolipoprotein B, Cardiac and Cardiovascular Systems, Humanized, Cardiovascular Diseases/diagnosis, Cardiology - Radboud University Medical Center, Kardiologi, Anticholesteremic Agents, drug therapy, 3. Good health, [SDV] Life Sciences [q-bio], Cholesterol, Treatment Outcome, PCSK9 inhibitors, Cardiovascular Diseases, epidemiology, Cardiology and Cardiovascular Disease, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Anticholesteremic Agents: adverse effects, prevention & control, Antibodies, Monoclonal, Humanized, PCSK9 inhibitors, acute coronary syndrome, apolipoproteins B, LDL cholesterol, Antibodies, acute coronary syndrome, LDL, 03 medical and health sciences, Radboudumc 16: Vascular damage RIHS: Radboud Institute for Health Sciences, Kardiologi och kardiovaskulära sjukdomar, cholesterol, LDL, Humans, Acute Coronary Syndrome, Apolipoproteins B, cholesterol, Atherosclerosis/drug therapy, Cholesterol, LDL, Cardiovascular risk, Atherosclerosis, Acute Coronary Syndrome/diagnosis, apolipoproteins B, Heart Disease Risk Factors, Hydroxymethylglutaryl-CoA Reductase Inhibitors

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/35770629
https://www.bib.irb.hr/1274171
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/283504
https://doi.org/10.1161/CIRCULATIONAHA.121.057807
https://hdl.handle.net/1887/3567819
https://repository.ubn.ru.nl/handle/2066/283504
https://repository.ubn.ru.nl//bitstream/handle/2066/283504/283504.pdf
https://pure.au.dk/ws/files/330044480/Apolipoprotein_B_Residual_Cardiovascular_Risk_After_Acute_Coronary_Syndrome_and_Effects_of_Alirocumab.pdf
https://hal.science/hal-04012895v1
https://doi.org/10.1161/circulationaha.121.057807
https://escholarship.org/uc/item/7z59p110
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-484248
https://publications.rwth-aachen.de/record/860665
http://www.scopus.com/inward/record.url?scp=85137105629&partnerID=8YFLogxK
https://pure.au.dk/ws/files/330044480/Apolipoprotein_B_Residual_Cardiovascular_Risk_After_Acute_Coronary_Syndrome_and_Effects_of_Alirocumab.pdf
https://doi.org/10.1161/CIRCULATIONAHA.121.057807
https://pure.au.dk/portal/en/publications/2f78bf21-2729-4f72-b0a6-e98aabbc4f9c

Reply to the Editor— Clinical potential of conduction system pacing versus biventricular pacing in heart failure: A trial sequential analysis and methodological comment

Authors: Iuri Ferreira Felix Michelle Collini Rafaela Fonseca et al.

Source: Heart Rhythm. 21:1182-1183

Subject Terms: Heart Failure, Cardiac Resynchronization Therapy, Heart Conduction System, Cardiac Pacing, Artificial, Humans

Access URL: https://pubmed.ncbi.nlm.nih.gov/38490598

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

Authors: Gregory G. Schwartz Michael Szarek Vera A. Bittner et al.

Contributors: Gregory G. Schwartz Michael Szarek Vera A. Bittner et al.

Source: J Am Coll Cardiol
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Schwartz, G G, Szarek, M, Bittner, V A, Diaz, R, Goodman, S G, Jukema, J W, Landmesser, U, López-Jaramillo, P, Manvelian, G, Pordy, R, Scemama, M, Sinnaeve, P, White, H D, Steg, P G & ODYSSEY OUTCOMES Committees and Investigators 2021, 'Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol', Journal of the American College of Cardiology, vol. 78, no. 5, pp. 421-433. https://doi.org/10.1016/j.jacc.2021.04.102
Schwartz, G G, Szarek, M, Bittner, V A, Diaz, R, Goodman, S G, Jukema, J W, Landmesser, U, López-Jaramillo, P, Manvelian, G, Pordy, R, Scemama, M, Sinnaeve, P, White, H D, Gabriel Steg, P, Gabriel Steg, P H, Bhatt, D L, Harrington, R A, Zeiher, A M, Tricoci, P, Roe, M T, Mahaffey, K W, Edelberg, J M, Hanotin, C, Lecorps, G, Moryusef, A, Sasiela, W J, Tamby, J F, Aylward, P E, Drexel, H, Sinnaeve, P, Dilic, M, Lopes, R D, Gotcheva, N N, Prieto, J C, Yong, H, Pećin, I, Reiner, Z, Clemmensen, P, Bang, L E, Hove, J D, Gislason, G, Larsen, J, Johansen, P, Jeppesen, J, Nielsen, P K, Hansen, O, Jensen, S A, Rosenberg, M, Andersen, D & ODYSSEY OUTCOMES Committees and Investigators 2021, ' Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol ', Journal of the American College of Cardiology, vol. 78, no. 5, pp. 421-433 . https://doi.org/10.1016/j.jacc.2021.04.102
Journal of The American College of Cardiology., New York : Elsevier Biomedical, 2021, vol. 78, no. 5, p. 421-433.
Journal of the American College of Cardiology, vol 78, iss 5

Subject Terms: Male, Cardiac & Cardiovascular Systems, acute coronary syndrom, MESH: Cholesterol, 0302 clinical medicine, lipoprotein(a), Monoclonal, Humanized, 1102 Cardiorespiratory Medicine and Haematology, MESH: Aged, RISK, MESH: Middle Aged, PCSK9 Inhibitors, acute coronary syndrome, low-density lipoprotein cholesterol, PCSK9 inhibitor, Middle Aged, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, 3. Good health, cholesterol PCSK9 inhibitor, Cholesterol, CARDIOVASCULAR-DISEASE, Cardiovascular Diseases, SAFETY, Female, Acute coronary syndrome, 3201 Cardiovascular medicine and haematology, Life Sciences & Biomedicine, LOW-DENSITY-LIPOPROTEIN, Antibodies, Monoclonal, Humanized, Cardiovascular medicine and haematology, Antibodies, Article, LDL, 1117 Public Health and Health Services, 03 medical and health sciences, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, MESH: PCSK9 Inhibitors, Humans, Low-density lipoprotein cholesterol, Acute Coronary Syndrome, Aged, MESH: Humans, Science & Technology, ODYSSEY Outcomes Committees and Investigators, MESH: Antibodies, ALIROCUMAB, MESH: Cardiovascular Diseases, Cholesterol, LDL, EFFICACY, MESH: Acute Coronary Syndrome, MESH: Male, Cardiovascular System & Hematology, low-density lipoprotein, Cardiovascular System & Cardiology, MESH: Lipoprotein(a), STATIN, CORONARY, MESH: Female, Lipoprotein(a)

File Description: application/pdf; 13 p

Access URL: https://pubmed.ncbi.nlm.nih.gov/34325831
https://hdl.handle.net/20.500.12530/59992
https://snucm.elsevierpure.com/en/publications/lipoproteina-and-benefit-of-pcsk9-inhibition-in-patients-with-nom
https://escholarship.org/content/qt402578cn/qt402578cn.pdf?t=qx3yri
https://research-repository.griffith.edu.au/handle/10072/406726
https://moh-it.pure.elsevier.com/en/publications/lipoproteina-and-benefit-of-pcsk9-inhibition-in-patients-with-nom
https://escholarship.org/uc/item/402578cn
https://einstein.pure.elsevier.com/en/publications/lipoproteina-and-benefit-of-pcsk9-inhibition-in-patients-with-nom
https://hdl.handle.net/1887/3274111
https://pure.au.dk/portal/en/publications/a015cc13-517f-4cd5-93cb-370d2e5d4ce1
https://curis.ku.dk/ws/files/301441214/Lipoprotein.pdf
https://repository.vu.lt/VU:ELABAPDB101603450&prefLang=en_US
https://repositorio.udes.edu.co/handle/001/6065
https://escholarship.org/uc/item/402578cn

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment

Authors: Gregory G. Schwartz Michael Szarek Vera A. Bittner et al.

Contributors: Gregory G. Schwartz Michael Szarek Vera A. Bittner et al.

Source: Diabetes Care
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid

Subject Terms: Cardiovascular and Metabolic Risk, Type 2* / epidemiology Double-Blind Method Humans Lipoprotein(a) Proprotein Convertase 9 Treatment Outcome, Anticholesteremic Agents, Antibodies, Monoclonal, Humanized, Antibodies, 3. Good health, 03 medical and health sciences, Type 2* / drug therapy Diabetes Mellitus, Treatment Outcome, 0302 clinical medicine, Diabetes Mellitus, Type 2, Double-Blind Method, Humanized Anticholesteremic Agents* Diabetes Mellitus, Monoclonal, Diabetes Mellitus, Humans, Proprotein Convertase 9, Humanized, Type 2, Antibodies, Monoclonal, Humanized Anticholesteremic Agents* Diabetes Mellitus, Type 2* / drug therapy Diabetes Mellitus, Type 2* / epidemiology Double-Blind Method Humans Lipoprotein(a) Proprotein Convertase 9 Treatment Outcome, Lipoprotein(a)

File Description: application/pdf

Access URL: https://figshare.com/articles/figure/Relation_of_Lipoprotein_a_Levels_to_Incident_Type_2_Diabetes_and_Modification_by_Alirocumab_Treatment/13805825/1/files/26750645.pdf
https://care.diabetesjournals.org/content/diacare/44/5/1219.full.pdf
https://escholarship.org/content/qt5h6931kv/qt5h6931kv.pdf?t=qq3qeq
https://pubmed.ncbi.nlm.nih.gov/33722880
https://hdl.handle.net/20.500.12530/59518
https://escholarship.org/uc/item/5h6931kv
https://www.ncbi.nlm.nih.gov/pubmed/33722880
https://researchnow.flinders.edu.au/en/publications/relation-of-lipoproteina-levels-to-incident-type-2-diabetes-and-m
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132323
https://escholarship.org/content/qt5h6931kv/qt5h6931kv.pdf?t=qq3qeq
http://care.diabetesjournals.org/content/early/2021/03/10/dc20-2842
https://hdl.handle.net/1887/3274114
https://escholarship.org/uc/item/5h6931kv

Electrophysiological study in chagasics with syncope and conduction disorder

Authors: Alexia Hallack Dreicon Luciana Armaganijan Dalmo Antonio Ribeiro Moreira et al.

Source: Rev Assoc Med Bras (1992)
Revista da Associação Médica Brasileira, Volume: 69, Issue: 12, Article number: e20230322, Published: 24 NOV 2023

Subject Terms: Male, Chagas disease, Bundle branch block, Bundle-Branch Block, Stroke Volume, Arrhythmias, Cardiac, Ventricular Function, Left, Syncope, 3. Good health, Electrocardiography, Humans, Original Article, Female, Chagas Disease, Electrophysiological study, Brazil, Retrospective Studies

File Description: text/html

Access URL: https://pubmed.ncbi.nlm.nih.gov/38055450
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302023001200628&lng=en&tlng=en